1f
12
9
1a
8
20
8
49
16
8
19
1
49
2
8
1b
1d
18
89
35
1d
2 29
1d
25
35
Adam M. Kruszewski, M.D.
4eAssistant Professor of Clinical Neurology
28
c1
3
60
Penn Medicine Clinician, Attending Physician, Division of Neuro-Ophthalmology, Dept. of Neurology, University of Pennsylvania, Philadelphia, PA
7
11
Department: Neurology
4
1
b
1d
46
Contact information
9e
4
3
3
3
2
4
b
1f
9e
3400 Spruce Street, 3 Gates Building, Hospital of the University of Pennsylvania
Philadelphia, PA 19104-4283
26
Philadelphia, PA 19104-4283
2e
Office: 215-662-3606
32 Fax: 215-243-2314
24
f
32 Fax: 215-243-2314
24
13
Education:
21 9 B.S. 63 (Biochemistry, With High Honors in Cell Biology and Molecular Genetics, Summa Cum Laude) c
41 University of Maryland, College Park, MD, 2013.
21 9 M.D. c
51 University of Maryland School of Medicine, Baltimore, MD, 2017.
c
3
3
21
21 9 B.S. 63 (Biochemistry, With High Honors in Cell Biology and Molecular Genetics, Summa Cum Laude) c
41 University of Maryland, College Park, MD, 2013.
21 9 M.D. c
51 University of Maryland School of Medicine, Baltimore, MD, 2017.
c
1f
Post-Graduate Training
24 4c Intern, Internal Medicine, Temple University Hospital, Philadelphia, PA 1b , 2017-2018.
24 56 Resident, Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA 1b , 2018-2021.
24 b9 Samantha and Michael Jordan Fellow in Neuro-Ophthalmology, Hospital of the University of Pennsylvania, Scheie Eye Institute, Children’s Hospital of Philadelphia, Philadelphia, PA 1b , 2021-2022.
c
3
25
24 4c Intern, Internal Medicine, Temple University Hospital, Philadelphia, PA 1b , 2017-2018.
24 56 Resident, Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA 1b , 2018-2021.
24 b9 Samantha and Michael Jordan Fellow in Neuro-Ophthalmology, Hospital of the University of Pennsylvania, Scheie Eye Institute, Children’s Hospital of Philadelphia, Philadelphia, PA 1b , 2021-2022.
c
17
Certifications
28 5f Neurology, Diplomate of the American Board of Psychiatry and Neurology, 2021.
c
3
8d
Permanent link28 5f Neurology, Diplomate of the American Board of Psychiatry and Neurology, 2021.
c
2 29
21
1e
1d
24
2b
29
27
23
130 Liu T, Chebolu AP, Chung CW, Kruszewski AM, Bhatt N, Brucker AJ: Bilateral uveitis, retinal periphlebitis, and optic neuritis associated with non-pineal central nervous system germinoma. Retin Cases Brief Rep 19: 182-186, Mar 2025.
c2 Kruszewski AM, Tamhankar MA.: Ophthalmic Manifestations of Giant Cell Arteritis. Int Ophthalmol Clin 63: 13-23, Apr 2023.
17c Kruszewski AM, Tauqeer Z, Meer EA, Bautista SA, Cherayil NR, Cimino ME, Khella SL, Lancaster E, Bird SJ, Scherer SS, Revere KE, Hamedani AG, Liu GT, Tamhankar MA.: Vision Loss as a Presenting Feature of Chronic Inflammatory Demyelinating Polyneuropathy: A Case Series. J Neuroophthalmol 43: 48-54, Mar 2023.
13d Kruszewski AM, Reid JE, Malik A, Maris JM, Liu GT.: Mydriasis as a side effect of dinutuximab immunotherapy in pediatric neuroblastoma: a case series. North American Neuro-Ophthalmology Society (NANOS) 48th Annual Meeting. Austin, TX. Feb 2022.
e3 Kruszewski AM, White BF, Ying GS, Fisher MJ, Storm PB, Avery RA, Liu GT.: Visual acuity outcomes after open versus endoscopic endonasal surgery for pediatric craniopharyngioma. 76 North American Neuro-Ophthalmology Society (NANOS) 48th Annual Meeting. Austin, TX. Feb 2022.
2cf Jurkute N, Bertacchi M, Arno G, Tocco C, Kim US, Kruszewski AM, Avery RA, Bedoukian EC, Han J, Ahn SJ, Pontikos N, Acheson J, Davagnanam I, Bowman R, Kaliakatsos M, Gardham A, Wakeling E, Oluonye N, Reddy MA, Clark E, Rosser E, Amati-Bonneau P, Charif M, Lenaers G, Meunier I, Defoort S, Vincent-Delorme C, Robson AG, Holder GE, Jeanjean L, Martinez-Monseny A, Vidal-Santacana M, Dominici C, Gaggioli C, Giordano N, Caleo M, Liu GT; Genomics England Research Consortium; Webster AR, Studer M, Yu-Wai-Man P.: Pathogenic NR2F1 variants cause a developmental ocular phenotype recapitulated in a mutant mouse model. Brain Commun 3: fcab162, Jul 2021.
c0 Jurkute N, Bertacchi M, Arno G, Tocco C, Kim U, Kruszewski AM, Avery RA, Bedoukian EC, Han J, Ahn S, Acheson J, Davagnanam I, Bowman R, Kaliakatsos 1be M, Reddy A, Oluonye N, Amati-Bonneau P, Charif M, Lenaers G, Meunier I, Defoort S, Vincent-Delorme C, Robson A, Holder G, Jeanjean L, Martinez-Monseny A, Liu GT, Webster A, Studer M, Yu-Wai-Man P. : Pathogenic NR2F1 variants cause a systemic neurodevelopmental ocular phenotype recapitulated in a mutant mouse model. North American Neuro-Ophthalmology Society (NANOS) 47th Annual Meeting, Virtual Meeting. Feb 2021.
ae Kruszewski AM, Tauqeer Z, Meer EA, Bautista SA, Cherayil NR, Khella SL, Scherer SS, Revere KE, Hamedani AG, Liu GT, Tamhankar MA. 64 : Vision Loss In Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Case Series. 5f North American Neuro-Ophthalmology Society (NANOS) 47th Annual Meeting, Virtual Meeting. 1e Feb 2021.
116 Tatomir A, Talpos-Caia A, Anselmo F, Kruszewski AM, Boodhoo D, Rus V, Rus H.: The complement system as a biomarker of disease activity and response to treatment in multiple sclerosis. Immunol Res Dec 2017.
2c
7
1d
1f
Selected Publications
14d Tomlinson SB, Rahmani R, Jabarkheel R, Kruszewski AM, Yoshor D, Srinivasan VM: Resolution of Symptomatic Intracranial Hypertension Following Resection of Tentorial Meningioma Compressing the Dominant Transverse Sinus. J Neurol Surg Rep 86: e170-e174, Jul 2025.130 Liu T, Chebolu AP, Chung CW, Kruszewski AM, Bhatt N, Brucker AJ: Bilateral uveitis, retinal periphlebitis, and optic neuritis associated with non-pineal central nervous system germinoma. Retin Cases Brief Rep 19: 182-186, Mar 2025.
c2 Kruszewski AM, Tamhankar MA.: Ophthalmic Manifestations of Giant Cell Arteritis. Int Ophthalmol Clin 63: 13-23, Apr 2023.
17c Kruszewski AM, Tauqeer Z, Meer EA, Bautista SA, Cherayil NR, Cimino ME, Khella SL, Lancaster E, Bird SJ, Scherer SS, Revere KE, Hamedani AG, Liu GT, Tamhankar MA.: Vision Loss as a Presenting Feature of Chronic Inflammatory Demyelinating Polyneuropathy: A Case Series. J Neuroophthalmol 43: 48-54, Mar 2023.
13d Kruszewski AM, Reid JE, Malik A, Maris JM, Liu GT.: Mydriasis as a side effect of dinutuximab immunotherapy in pediatric neuroblastoma: a case series. North American Neuro-Ophthalmology Society (NANOS) 48th Annual Meeting. Austin, TX. Feb 2022.
e3 Kruszewski AM, White BF, Ying GS, Fisher MJ, Storm PB, Avery RA, Liu GT.: Visual acuity outcomes after open versus endoscopic endonasal surgery for pediatric craniopharyngioma. 76 North American Neuro-Ophthalmology Society (NANOS) 48th Annual Meeting. Austin, TX. Feb 2022.
2cf Jurkute N, Bertacchi M, Arno G, Tocco C, Kim US, Kruszewski AM, Avery RA, Bedoukian EC, Han J, Ahn SJ, Pontikos N, Acheson J, Davagnanam I, Bowman R, Kaliakatsos M, Gardham A, Wakeling E, Oluonye N, Reddy MA, Clark E, Rosser E, Amati-Bonneau P, Charif M, Lenaers G, Meunier I, Defoort S, Vincent-Delorme C, Robson AG, Holder GE, Jeanjean L, Martinez-Monseny A, Vidal-Santacana M, Dominici C, Gaggioli C, Giordano N, Caleo M, Liu GT; Genomics England Research Consortium; Webster AR, Studer M, Yu-Wai-Man P.: Pathogenic NR2F1 variants cause a developmental ocular phenotype recapitulated in a mutant mouse model. Brain Commun 3: fcab162, Jul 2021.
c0 Jurkute N, Bertacchi M, Arno G, Tocco C, Kim U, Kruszewski AM, Avery RA, Bedoukian EC, Han J, Ahn S, Acheson J, Davagnanam I, Bowman R, Kaliakatsos 1be M, Reddy A, Oluonye N, Amati-Bonneau P, Charif M, Lenaers G, Meunier I, Defoort S, Vincent-Delorme C, Robson A, Holder G, Jeanjean L, Martinez-Monseny A, Liu GT, Webster A, Studer M, Yu-Wai-Man P. : Pathogenic NR2F1 variants cause a systemic neurodevelopmental ocular phenotype recapitulated in a mutant mouse model. North American Neuro-Ophthalmology Society (NANOS) 47th Annual Meeting, Virtual Meeting. Feb 2021.
ae Kruszewski AM, Tauqeer Z, Meer EA, Bautista SA, Cherayil NR, Khella SL, Scherer SS, Revere KE, Hamedani AG, Liu GT, Tamhankar MA. 64 : Vision Loss In Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Case Series. 5f North American Neuro-Ophthalmology Society (NANOS) 47th Annual Meeting, Virtual Meeting. 1e Feb 2021.
116 Tatomir A, Talpos-Caia A, Anselmo F, Kruszewski AM, Boodhoo D, Rus V, Rus H.: The complement system as a biomarker of disease activity and response to treatment in multiple sclerosis. Immunol Res Dec 2017.
2c